About Us

BioMed Design, LLC was created in October 2005 and is owned by Jean-Marie Girardot, PhD, Marie-Nadia Girardot, PhD, and Marc Girardot, MBA. Together with Biomedical Design, Inc., we have developed a portfolio of patents for technologies in the medical device industry and have extensive research, development, and marketing experience in the implantable soft tissue market. The company is currently focused on finding new markets for the BDLink™ and BDSter™ technologies.

Company History

BioMed Design is closely tied to Biomedical Design, Inc., which was incorporated in 1987 in Atlanta, GA and is operated by the owners, husband/wife team Dr. Jean-Marie Girardot and Dr. Marie-Nadia Girardot. The company is focused on research in the field of implantable biological tissue.

Biomedical Design has a history of success in developing tissue heart valve technologies. We developed AOA®, the first successful anti-calcification treatment for heart valve bioprostheses. Our researchers also developed BDLink™ and BDSter™, and formed a new company called Pegasus Biologics in 2005. Pegasus was acquired by Synovis Life Technologies in 2009.

AOA® is a registered trademark of Medtronic, Inc.

Key Personnel

Marc Girardot, MBA CEO and Busines Development Director
Marc Girardot brings over 10 years of combined experience in the pharmaceutical and medical device industries. He is a founding member of BioMed Design, LLC, where he has been instrumental in successfully selling trademarks and licensing patented technologies for the chemical treatment of implantable biological materials. Prior to BioMed Design, Marc Girardot worked in discovery R&D groups at Boehringer-Ingelheim and AstraZeneca as a medicinal chemist, and in marketing at Solvay Pharmaceuticals, where he provided actionable marketing recommendations and created an internal scenario planning process. Marc Girardot holds a Master in Business Administration (MBA) from Emory University’s Goizueta Business School and a Bachelor’s degree in Chemistry from Boston University.

Jean-Marie Girardot, PhD Inventor
Dr. Jean-Marie Girardot is Founder and CEO of Biomedical Design, Inc. and Managing Member of BioMed Design, LLC. Biomedical Design was founded in 1987 to develop and commercialize the alpha amino oleic acid anticalcification technology for the treatment of heart valve bioprostheses. Jean-Marie Girardot has over 25 years experience in the Medical Device Industry and is the author or co-author of numerous peer-reviewed scientific papers, book chapters and several US and International patents. He holds a Ph.D. in Biochemistry and Molecular Biology from the University of Oklahoma Health Sciences Center.

Nadia Girardot, PhD Inventor
Dr. Nadia Girardot is President of Biomedical Design, Inc. and Managing Member of BioMed Design, LLC, with over 25 years of experience as inventor, developer and licensor of technologies for the chemical treatment of implantable biological materials. In this process, she has successfully brought anti-calcification, cross-linking and sterilization technologies from concept to patent to licensing. Nadia Girardot is also the author of numerous scientific and medical international manuscripts and book chapters. She holds a B.S. from the University Louis Pasteur, Strasbourg, France, and a M.S. and a Ph.D. from the University of Oklahoma Health Sciences Center. Dr. Nadia Girardot is a Chevalier de l’Ordre National du Merite.


Drs. Jean-Marie and Nadia Girardot are the authors of more than 30 refereed manuscripts and book chapters that have been published internationally. They have also presented numerous times to the scientific and medical community. Marc Girardot is also an author of several peer-reviewed scientific publications.